Comparative Review of Seizure and Cognitive Outcomes in Resective, Ablative, and Neuromodulatory Temporal Lobe Epilepsy Surgery
- PMID: 40028188
- PMCID: PMC11869217
- DOI: 10.1177/15357597251318564
Comparative Review of Seizure and Cognitive Outcomes in Resective, Ablative, and Neuromodulatory Temporal Lobe Epilepsy Surgery
Abstract
Resective surgery for drug-resistant temporal lobe epilepsy remains underutilized in the United States. While anteromesial temporal lobectomy consistently achieves the highest rates of long-term seizure freedom, it comes with greater risks for memory and language decline. Magnetic resonance imaging-guided laser interstitial thermal therapy and neuromodulation have gained popularity due to perceived lower surgical risk and faster recovery, although they yield lower rates of sustained seizure freedom. Neuromodulation with vagus nerve, deep brain, or responsive neurostimulation provides an option for patients ineligible for resection or ablation, but overall seizure outcomes remain modest. Balancing improved seizure control with open resection against the potential cognitive advantages of less invasive treatments is complex, requiring careful patient selection. Future research must refine these approaches to optimize results. Thoughtful, individualized decision-making, guided by each patient's clinical scenario and goals, is paramount for achieving the best balance between seizure freedom, cognitive preservation, and overall patient outcome.
Keywords: cognitive outcomes; deep brain stimulation; lobectomy; neuromodulation; responsive neurostimulation; seizure outcomes; temporal lobe epilepsy; vagal nerve stimulator.
© The Author(s) 2025.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Lara Jehi, Robyn Busch, Brett Youngermann, and Demitre Serletis: Nothing to disclose; Patricia Dugan: Consultant for NeuroPace. Receives research funding from NeuroPace. Chengyuan Wu: consulting fees: BrainLab, Medtronic, NeuroOne, Renishaw. Daniel Drane: organization received a contract with Medtronic to manage the data acquisition and analysis (MRI and NP data) for their FDA trial of laser ablation (SLATE).
Similar articles
-
The landscape of epilepsy surgery in older adults: Challenges and opportunities.Epilepsia Open. 2025 Aug;10(4):1009-1022. doi: 10.1002/epi4.70062. Epub 2025 May 19. Epilepsia Open. 2025. PMID: 40388418 Free PMC article. Review.
-
Chronic unlimited recording electrocorticography-guided resective epilepsy surgery: technology-enabled enhanced fidelity in seizure focus localization with improved surgical efficacy.J Neurosurg. 2014 Jun;120(6):1402-14. doi: 10.3171/2014.1.JNS131592. Epub 2014 Mar 21. J Neurosurg. 2014. PMID: 24655096
-
Minimally invasive surgical approaches for temporal lobe epilepsy.Epilepsy Behav. 2015 Jun;47:24-33. doi: 10.1016/j.yebeh.2015.04.033. Epub 2015 May 24. Epilepsy Behav. 2015. PMID: 26017774 Free PMC article. Review.
-
Long-term outcomes after responsive neurostimulation for treatment of refractory epilepsy: a single-center experience of 100 cases.J Neurosurg. 2023 Mar 31;139(5):1463-1470. doi: 10.3171/2023.2.JNS222116. Print 2023 Nov 1. J Neurosurg. 2023. PMID: 37655833
-
Less is more: novel less-invasive surgical techniques for mesial temporal lobe epilepsy that minimize cognitive impairment.Curr Opin Neurol. 2015 Apr;28(2):182-91. doi: 10.1097/WCO.0000000000000176. Curr Opin Neurol. 2015. PMID: 25692411 Review.
References
Publication types
LinkOut - more resources
Full Text Sources